Literature DB >> 2620793

Acute toxicity of perfluorodecanoic acid in C57BL/6 mice differs from 2,3,7,8-tetrachlorodibenzo-p-dioxin.

M W Harris1, L C Uraih, L S Birnbaum.   

Abstract

Perfluorodecanoic acid (PFDA) is a 10-carbon straight-chain fatty acid. Its toxicity in rats has been reported to resemble that produced by exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Mice which are "responsive" to TCDD toxicity carry the Ahb allele, while mice homozygous for the Ahd gene are less sensitive to TCDD toxicity. To characterize the toxicity of PFDA and determine if it is under the control of the Ah locus, female responsive C57BL/6N (Ahb/b) mice and congenic C57BL/6J mice, differing only at the Ah locus (responsive, Ahb/b; heterozygous responsive, Ahb/d and "nonresponsive," Ahd/d), were administered a single oral dose of PFDA, at levels from 0 to 320 mg/kg body weight, observed daily for overt signs of toxicity, and weighed three times weekly. In the wild-type congenic C57BL/6J (Ahb/b) subline, mice were killed at 2, 7, 14, and 30 days following exposure. All other mice were killed on Day 30. Serum was taken from the C57BL/6N mice for analysis of thyroid hormone levels. Selected organs from all mice were weighed and fixed for histopathological examination. Dose-related mortality was observed as early as 5 days postexposure and time-to-death was inversely related to dose. Dramatic decreases in body weight occurred shortly following treatment in all strains. Serum triiodothyronine (T3) and thyroxine (T4) levels increased with increasing dose. There was a marked increase (p less than 0.05) in absolute and relative liver weights and a significant decrease in thymus weights. Hepatocellular hypertrophy was observed in all treated mice other than controls. A marked increase in hepatocyte peroxisomes was observed in all treatment groups. Thus, in contrast to TCDD, the acute toxicity of PFDA in the female C57BL/6 mouse does not vary with the Ah allele and is distinct from that reported for TCDD.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2620793     DOI: 10.1016/0272-0590(89)90330-8

Source DB:  PubMed          Journal:  Fundam Appl Toxicol        ISSN: 0272-0590


  5 in total

1.  Effects of peroxisome proliferators on the thymus and spleen of mice.

Authors:  Q Yang; Y Xie; J W Depierre
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

2.  Effects of perfluoroalkyl acids on the function of the thyroid hormone and the aryl hydrocarbon receptor.

Authors:  Manhai Long; Mandana Ghisari; Eva Cecilie Bonefeld-Jørgensen
Journal:  Environ Sci Pollut Res Int       Date:  2013-03-29       Impact factor: 4.223

3.  Critical role of PPAR-alpha in perfluorooctanoic acid- and perfluorodecanoic acid-induced downregulation of Oatp uptake transporters in mouse livers.

Authors:  Xingguo Cheng; Curtis D Klaassen
Journal:  Toxicol Sci       Date:  2008-08-14       Impact factor: 4.849

4.  Nrf2- and PPAR alpha-mediated regulation of hepatic Mrp transporters after exposure to perfluorooctanoic acid and perfluorodecanoic acid.

Authors:  Jonathan M Maher; Lauren M Aleksunes; Matthew Z Dieter; Yuji Tanaka; Jeffrey M Peters; Jose E Manautou; Curtis D Klaassen
Journal:  Toxicol Sci       Date:  2008-08-29       Impact factor: 4.849

5.  Perfluorodecanoic acid (PFDA) promotes gastric cell proliferation via sPLA2-IIA.

Authors:  Tianyi Dong; Yanping Peng; Ning Zhong; Fengyan Liu; Hanyu Zhang; Mengchen Xu; Rutao Liu; Mingyong Han; Xingsong Tian; Jihui Jia; Lap Kam Chang; Liang-Hong Guo; Shili Liu
Journal:  Oncotarget       Date:  2017-04-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.